Alembic Pharma gets USFDA nod for Parkinson’s treatment drug

New Delhi: Drug firm Alembic Pharmaceuticals Thursday said it has received approval from the US health regulator for Pramipexole Dihydrochloride extended-release tablets used for the treatment of Parkinson’s disease. The approval from the United States Food and Drug Administration (USFDA) is for the company’s abbreviated new drug application (ANDA) for Pramipexole Dihydrochloride extended-release tablets, in the strengths of 0.375 mg, 0.75 mg, 1.5 mg, 2.25 mg, 3 mg, 3.75 mg, and 4.5 mg, Alembic Pharmaceuticals said in a filing to BSE.

The approved product is a therapeutic equivalent to the reference listed drug product (RLD) Mirapex ER tablets, of Boehringer lngelheim Pharmaceuticals Inc.

Quoting IQVIA data, Alembic Pharma said Pramipexole Dihydrochloride extended-release tablets have an estimated market size of USD 38.6 million for twelve months ending December 2017.

The company currently has a total of 84 ANDA approvals (71 final approvals and 13 tentative approvals) from USFDA, it added.

Shares of Alembic Pharmaceuticals were trading at Rs 587.05 apiece on BSE, up 1.04 per cent from its previous close.

  • Related Posts

    Price cap on 2 key cancer drugs increased by 50%

    NEW DELHI: Amid concerns over shortages of two critical cancer medicines, National Pharmaceutical Pricing Authority has approved a 50% hike in ceiling prices of Carboplatin and Cisplatin injections, citing escalating…

    Hospitals can’t force patients to buy medicines from their pharmacies: Maha FDA

    Mumbai: Food and Drug Administration (FDA) commissioner Tukaram Mundhe on Friday issued a directive to hospitals and nursing homes across the state to not make it binding on patients and their…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Price cap on 2 key cancer drugs increased by 50%

    Price cap on 2 key cancer drugs increased by 50%

    Hospitals can’t force patients to buy medicines from their pharmacies: Maha FDA

    Hospitals can’t force patients to buy medicines from their pharmacies: Maha FDA

    IIT Bhubaneswar researchers develop portable device for accurate arsenic detection

    IIT Bhubaneswar researchers develop portable device for accurate arsenic detection

    Bribe of Rs 3 crore: Delhi Police inspector held, senior public servant under CBI scanner

    Bribe of Rs 3 crore: Delhi Police inspector held, senior public servant under CBI scanner

    No raids till further orders: Maharashtra tells Bombay HC in Patanjali labelling case

    No raids till further orders: Maharashtra tells Bombay HC in Patanjali labelling case

    Crackdown on Illegal Sale of Mephentermine Sulphate Injections in Warangal Gyms

    Crackdown on Illegal Sale of Mephentermine Sulphate Injections in Warangal Gyms